Embark Stock
HealthTechLooking to sell Embark stock or options?
Embark, the creator of a DNA testing kit aimed at enhancing canine health and wellness, offers a tool that identifies genetic markers to provide dog owners with crucial health data. This kit not only delivers ancestry analysis but also uncovers potential genetic disease risks and inheritable traits. With just a simple cheek swab, it equips pet owners with comprehensive insights into their dog's breed, health, and possible diseases.
SV Angel, Kevin M. McGovern Family Center for Venture Development in the Life Sciences, Anne Wojcicki, Notley Ventures, Freestyle Capital, Eight Roads, Capital Factory, F-Prime Capital, The Finger Group, S32, Slow Ventures, Peak Opportunity Partners, AGO Partners, Founder Collective, Material Companies, 3rdKind, FJ Labs, Third Kind Venture Capital, Seth Flowerman, SoftBank Investment Advisers.